Skip to main content
Caplight Logo









Sixfold Bioscience

Sixfold Bioscience

Private
LondonHealthcare & Life Scienceshttps://www.sixfold.bio/

Last Round

Grant

Aug 22, 2023

Total Funding Raised

$13.24M

Company Overview

Sixfold Bioscience is a biotechnology company that develops programmable drug delivery systems for RNA therapeutics using computation and advanced chemistry.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

drug deliveryRNA therapeuticsgenetic medicineMerlin platformMergobiotech platformdrug delivery platformtissue targetingmachine learning drug discoveryAI-driven biotechpreclinical researchRNA deliverybiotech R&Ddrug delivery techdelivery vehicle

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sixfold Bioscience Comparables

Compare Sixfold Bioscience with similar companies based on industry and business-model similarity.

Sixfold Bioscience comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Nuntius Therapeutics
88%
ParcelBio
85%
AbbVie
77%

Sixfold Bioscience Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantAug 22, 2023
GrantMar 1, 2023
SeedDec 2, 2021
GrantSep 23, 2020
GrantAug 4, 2020
Grant
Sep 17, 2019

Key People

Founding team and executive leadership

George Foot

Founder co-CEO

Founding Team

Sixfold Bioscience Investors

Notable investors and investment history

Sixfold Bioscience investors
InvestorRounds
Innovate UKGrant
Pi CampusSeed
European CommissionSeed
Cantos VenturesSeed
Innovate UKSeed, Grant
Y CombinatorSeed, Accelerator
Lombardstreet VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2023

    $960K grant received from Innovate UK.

  • Mar 1, 2023

    $1M raised from Innovate UK.

Sixfold Bioscience Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Sixfold Bioscience Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Sixfold Bioscience's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range8
Year Founded2017
Last FundingAug 22, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?